Keyword: GlaxoSmithKline (GSK)
News
22.03.2016
- Britain’s largest pharmaceutical company, Glaxo SmithKline (GSK), has formed a strategic collaboration with German biotechnology firm Miltenyi Biotec to develop cell and gene...
News
18.03.2016
- It’s official. Andrew Witty, CEO of Britain’s largest drugmaker, Glaxo SmithKline (GSK), has announced he will retire in March 2017 after nearly a decade at the helm. In a...
News
16.03.2016
- AstraZeneca shareholders are said to be questioning the £8.4 million pay package awarded to CEO executive Pascal Soriot last year after he successfully deflected a hostile bid from...
News
15.03.2016
- British drugmaker Glaxo SmithKline (GSK) has pulled out of a five-year deal with US biotechnology company Five Prime to develop experimental cancer drug FP-1039. Buried in Five...
News
01.03.2016
- British drugmaker GlaxoSmithKline is said to have launched a search for a new CEO to replace Andrew Witty, who is now widely expected to step down at the latest by the end of 2017...
News
15.02.2016
- Major UK drugs firm GlaxoSmithKline (GSK) has been fined more than £37 million by the Competition and Markets Authority (CMA) for anti-competitive behavior relating to generic...
News
05.02.2016
- Glaxo SmithKline CEO Andrew Witty has become the first pharmaceutical or chemical company executive to come out in favor of the UK remaining in the EU, although business leaders in...
News
05.02.2016
- Major drugs companies Johnson & Johnson (J&J) and GlaxoSmithKline (GSK) have become partners in a €210 million life sciences venture capital fund. Both groups will each contribute...
